ATE245028T1 - Trimegestone enthaltende pharmazeutische zusammensetzungen - Google Patents

Trimegestone enthaltende pharmazeutische zusammensetzungen

Info

Publication number
ATE245028T1
ATE245028T1 AT00981453T AT00981453T ATE245028T1 AT E245028 T1 ATE245028 T1 AT E245028T1 AT 00981453 T AT00981453 T AT 00981453T AT 00981453 T AT00981453 T AT 00981453T AT E245028 T1 ATE245028 T1 AT E245028T1
Authority
AT
Austria
Prior art keywords
pharmaceutical compositions
compositions containing
trimegestone
containing trimegestone
composition
Prior art date
Application number
AT00981453T
Other languages
English (en)
Inventor
Philippe Becourt
Robert Georges
Chicq Serge Segot
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Application granted granted Critical
Publication of ATE245028T1 publication Critical patent/ATE245028T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT00981453T 1999-11-23 2000-11-22 Trimegestone enthaltende pharmazeutische zusammensetzungen ATE245028T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9914714A FR2801218B1 (fr) 1999-11-23 1999-11-23 Compositions pharmaceutiques comprenant de la trimegestone, leurs procedes de preparation ainsi que le conditionnement primaire les renfermant
PCT/FR2000/003240 WO2001037841A1 (fr) 1999-11-23 2000-11-22 Compositions pharmaceutiques comprenant de la trimegestone

Publications (1)

Publication Number Publication Date
ATE245028T1 true ATE245028T1 (de) 2003-08-15

Family

ID=9552429

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00981453T ATE245028T1 (de) 1999-11-23 2000-11-22 Trimegestone enthaltende pharmazeutische zusammensetzungen

Country Status (11)

Country Link
US (1) US7732431B2 (de)
EP (1) EP1235579B1 (de)
JP (1) JP5060005B2 (de)
AT (1) ATE245028T1 (de)
AU (1) AU1869601A (de)
DE (1) DE60003943T2 (de)
DK (1) DK1235579T3 (de)
ES (1) ES2200978T3 (de)
FR (1) FR2801218B1 (de)
PT (1) PT1235579E (de)
WO (1) WO2001037841A1 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200306846A (en) * 2002-04-03 2003-12-01 Wyeth Corp Hormone replacement therapy
TW200306196A (en) * 2002-04-03 2003-11-16 Wyeth Corp Hormone replacement therapy
TW200400040A (en) * 2002-05-17 2004-01-01 Wyeth Corp Hormone replacement therapy
DE102005034498A1 (de) * 2005-07-20 2007-01-25 Grünenthal GmbH Orale Kontrazeption mit Trimegeston
AU2006271920A1 (en) * 2005-07-20 2007-01-25 Grunenthal Gmbh Oral contraception with trimegestone
EP2108371A1 (de) * 2008-04-08 2009-10-14 Grünenthal GmbH Estra-1,3,5(10)-trien-Derivate zur Kontrazeption
WO2012058463A2 (en) 2010-10-27 2012-05-03 Dignity Health Trimegestone (tmg) for treatment of preterm birth
JP6449274B2 (ja) 2013-07-11 2019-01-09 エベストラ インコーポレイテッド プロドラッグを生成する化合物
RU2019126483A (ru) 2017-01-23 2021-02-24 Ридженерон Фармасьютикалз, Инк. Варианты 17-бета-гидроксистероиддегидрогеназы 13 (hsd17b13) и их применение
KR20190139869A (ko) * 2017-04-11 2019-12-18 리제너론 파마슈티칼스 인코포레이티드 하이드록시스테로이드 (17-베타) 탈수소효소(hsd17b) 패밀리의 구성원의 조절인자의 활성도를 스크리닝하기 위한 검정
AU2018348195B2 (en) 2017-10-11 2025-05-15 Regeneron Pharmaceuticals, Inc. Inhibition of HSD17B13 in the treatment of liver disease in patients expressing the PNPLA3 I148M variation
MX2020003470A (es) 2017-10-19 2020-10-01 Evestra Inc Anticonceptivos de profarmacos de progestina de accion mas prolongada.
AU2019239971B2 (en) 2018-03-21 2025-09-11 Regeneron Pharmaceuticals, Inc. 17beta-hydroxysteroid dehydrogenase type 13 (HSD17b13) iRNA compositions and methods of use thereof
KR102769565B1 (ko) 2018-09-19 2025-02-20 애로우헤드 파마슈티컬스 인코포레이티드 17베타-HSD 유형 13- (HSD17B13)의 발현을 억제하기 위한 RNAi 작용제, 그의 조성물, 및 사용 방법

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4239646A (en) * 1974-09-23 1980-12-16 Champion International Corporation Microspheric opacifying agents and method for their production
US4761406A (en) * 1985-06-06 1988-08-02 The Procter & Gamble Company Regimen for treating osteoporosis
IE67345B1 (en) * 1991-03-12 1996-03-20 Akzo Nv Low dose dry pharmaceutical preparations
FR2692267B1 (fr) * 1992-06-11 1995-05-19 Roussel Uclaf Nouveau procédé de préparation de composés stéroïdes 20-céto 21alpha-hydroxy et intermédiaires.
FR2694007B1 (fr) * 1992-07-23 1994-09-30 Roussel Uclaf Nouveau procédé de préparation de composés stéroïdes 20-céto 21 (S) hydroxy et des intermédiaires.
US5759577A (en) * 1995-01-17 1998-06-02 American Home Products Corporation Controlled release of steroids from sugar coatings
US5547948A (en) * 1995-01-17 1996-08-20 American Home Products Corporation Controlled release of steroids from sugar coatings
DE69620607T2 (de) * 1995-06-22 2002-09-19 Akzo Nobel N.V., Arnheim/Arnhem Trockengranulierte gepresste tabletten enthaltend desogestrel
FR2749012B1 (fr) * 1996-05-22 1998-08-07 Hoechst Marion Roussel Inc Nouveaux steroides 1 ou 6-hydroxyles, leur procede de preparation, leur application a titre de medicament et les compositions pharmaceutiques les renfermant
CN1119999C (zh) * 1996-07-26 2003-09-03 惠氏公司 口服避孕药
DE69729956T2 (de) * 1996-07-26 2004-12-16 Wyeth Orale einstufige empfängnisverhütungsmethode und kombinationspräparat das gestagen und estrogen enthält
DE69724796T2 (de) * 1996-07-26 2004-07-01 Wyeth Biphasische orale verhuetungsmethode und kit die eine kombination von progestin und eines oestrogens enthalten
WO1998004246A2 (en) * 1996-07-26 1998-02-05 American Home Prod Triphasic contraceptive method and kit comprising a combination of a progestin and estrogen
US5858405A (en) 1996-07-26 1999-01-12 American Home Products Corporation Oral contraceptive
SG125044A1 (en) * 1996-10-14 2006-09-29 Mitsubishi Gas Chemical Co Oxygen absorption composition
US6329416B1 (en) 1999-05-04 2001-12-11 American Home Products Corporation Combination regimens using 3,3-substituted indoline derivatives

Also Published As

Publication number Publication date
FR2801218B1 (fr) 2001-12-28
JP5060005B2 (ja) 2012-10-31
DE60003943D1 (de) 2003-08-21
EP1235579B1 (de) 2003-07-16
ES2200978T3 (es) 2004-03-16
EP1235579A1 (de) 2002-09-04
DE60003943T2 (de) 2004-05-27
WO2001037841A1 (fr) 2001-05-31
US7732431B2 (en) 2010-06-08
US20070219169A1 (en) 2007-09-20
JP2003514861A (ja) 2003-04-22
PT1235579E (pt) 2003-12-31
FR2801218A1 (fr) 2001-05-25
DK1235579T3 (da) 2003-10-20
AU1869601A (en) 2001-06-04

Similar Documents

Publication Publication Date Title
CY1112687T1 (el) Μεθοδος για χρηση δικετοπιπεραζινων και συνθεσεις που περιλαμβανουν αυτες
IL136285A0 (en) Pharmaceutical compositions containing an acid-labile active component
MY126897A (en) Anticonvulsant derivatives useful for preventing the development of type ii diabetes mellitus and syndrome x
ES2114487B1 (es) Mezcla estabilizante sinergistica.
YU15299A (sh) Farmaceutski sastavi
SE9704546D0 (sv) Novel compounds
PT1073470E (pt) Composicoes farmaceuticas contendo compostos com actividade capaz de melhorar a absorcao de ingredientes activos
EP0960621A3 (de) Pharmazeutische Zusammensetzungen enthaltend sildenafil
DE60003943D1 (de) Trimegestone enthaltende pharmazeutische zusammensetzungen
IL133397A (en) Pharmaceutical compositions for oral administration comprising an active substance and a cyclodextrin
GB2364641A (en) Stabilized oral pharmaceutical composition containing iodide and iodate and method
TR200100054T2 (tr) Paroksetin metansülfonat
MY124487A (en) Dolastatin derivatives, their preparation and use
YU13301A (sh) Muskarinski agonisti i antagonisti
TR199501645A2 (tr) Agiz bilesimleri.
AU5892399A (en) 1, 2, 4-triazole-3-thione compounds
TR200201459T2 (tr) Okzkarbazepin içeren süspansiyon
DE69120287D1 (en) Aminosulfonylharnstoff-acat-inhibitoren
BG101401A (bg) Състави за орално приложение с удължено освобождаване на цисаприд
BG105539A (bg) Елетриптан хидробромид монохидрат
MX9708394A (es) Composicion farmaceutica que contiene clorhidrato de tiagabina y el proceso para su preparacion.
AU4925200A (en) Oral composition containing perlite
IL109866A (en) Crystalline 3-(4-hexyloxy-1,2,5-thiadiazol-3-yl)-1,2,5,6-tetrahydro-1-methylpyridine(+)L-hydrogentartrate its preparation and pharmaceutical compositions containing it
MXPA01011296A (es) Composiciones contraceptivas que contienen derivados de indolina y agentes progestacionales.
DE69900466D1 (de) Orale zusammensetzungen mit niedrigdosierten zytotoxischen proteinen

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1235579

Country of ref document: EP